Treatment for many gastrointestinal cancers is becoming increasingly personalized, thanks to advances in genetic research, targeted therapies and a deeper understanding of how individual tumors behave.

Gynecologic cancers affect thousands of women each year, yet many remain difficult to detect in their earliest stages.

When it comes to breast cancer, what specifically does early detection mean today -- and what do women often overlook about their own risk and possible treatment options?

Early detection of breast cancer is crucial, with Dr. Hadeel Assad from Karmanos Cancer Institute emphasizing the importance of screenings and awareness

A cancer diagnosis is devastating and can be confusing. With so many different treatments available, how do you make sure you’re getting the right treatment plan?

Dr. Frank McGeorge talked with the Director of Breast Imaging at the Karmanos Cancer Institute in Detroit about ways to screen for breast cancer beyond mammograms and the importance of every woman getting a basic breast cancer risk assessment.

A cancer symposium being held in September will answer all of your family's questions

For 40% of women with dense breast tissue, their annual mammogram isn’t enough to detect early breast cancer. But now, a new technology called SoftVue may improve early detection, and the Karmanos Cancer Institute had its first patient undergo the new imaging Thursday.

Local 4 anchor Kimberly Gill was honored Wednesday in the 2021 Heroes of Cancer virtual event for coverage on Dr. Isaac Powell’s study on prostate cancer among Black men.

Powell, a doctor of urologic oncology at Karmanos Cancer Institute, specializes in prostate cancer. Local 4 is profiling Dr. Powell for Black History Month as a change maker in our community. MORE: Black History Month StoriesPowell grew up in Gary, Indiana and always knew he wanted to study medicine. So that was a devastating blow and that was my first actual, my first case of exposure to racism,” Powell said. Powell went on to medical school and became a successful surgeon, and thought leader in prostate cancer research.